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Purpose: To evaluate associations between pulmonary function and 
both quantitative analysis and visual assessment of thin-
section computed tomography (CT) images at baseline 
and at 15-month follow-up in subjects with idiopathic pul-
monary fibrosis (IPF).
Materials and 
Methods:
This retrospective analysis of preexisting anonymized 
data, collected prospectively between 2007 and 2013 in a 
HIPAA-compliant study, was exempt from additional insti-
tutional review board approval. The extent of lung fibrosis 
at baseline inspiratory chest CT in 280 subjects enrolled 
in the IPF Network was evaluated. Visual analysis was per-
formed by using a semiquantitative scoring system. Com-
puter-based quantitative analysis included CT histogram-
based measurements and a data-driven textural analysis 
(DTA). Follow-up CT images in 72 of these subjects were 
also analyzed. Univariate comparisons were performed by 
using Spearman rank correlation. Multivariate and longi-
tudinal analyses were performed by using a linear mixed 
model approach, in which models were compared by us-
ing asymptotic x2 tests.
Results: At baseline, all CT-derived measures showed moderate 
significant correlation (P , .001) with pulmonary func-
tion. At follow-up CT, changes in DTA scores showed 
significant correlation with changes in both forced vital 
capacity percentage predicted (r = 20.41, P , .001) and 
diffusing capacity for carbon monoxide percentage pre-
dicted (r = 20.40, P , .001). Asymptotic x2 tests showed 
that inclusion of DTA score significantly improved fit of 
both baseline and longitudinal linear mixed models in the 
prediction of pulmonary function (P , .001 for both).
Conclusion: When compared with semiquantitative visual assessment 
and CT histogram-based measurements, DTA score pro-
vides additional information that can be used to predict 
diminished function. Automatic quantification of lung fi-
brosis at CT yields an index of severity that correlates 
with visual assessment and functional change in subjects 
with IPF.
q RSNA, 2017
Stephen M. Humphries, PhD
Kunihiro Yagihashi, MD
Jason Huckleberry, MD
Byung-Hak Rho, MD
Joyce D. Schroeder, MD
Matthew Strand, PhD
Marvin I. Schwarz, MD
Kevin R. Flaherty, MD
Ella A. Kazerooni, MD
Edwin J. R. van Beek, MD
David A. Lynch, MB
idiopathic Pulmonary Fibrosis: 
Data-driven Textural Analysis of Extent 
of Fibrosis at Baseline and 15-Month 
Follow-up1
This copy is for personal use only. To order printed copies, contact reprints@rsna.org
Radiology: Volume 285: Number 1—October 2017 n radiology.rsna.org 271
THORACIC IMAGING: Idiopathic Pulmonary Fibrosis Humphries et al
Our group has developed a com-
puter algorithm, dubbed data-driven 
textural analysis (DTA), which is ca-
pable of quantifying the extent of lung 
fibrosis on CT images. On the basis of 
initial technical validation (7), we hy-
pothesized that serial DTA measure-
ments are predictive of progression in 
patients with IPF. The purpose of this 
work was to evaluate associations be-
tween pulmonary function and both 
quantitative analysis and visual assess-
ment of thin-section CT images at base-
line and 15-month follow-up in patients 
with IPF.
Materials and Methods
The original prospective study (8–10) 
was compliant with the Health Insur-
ance Portability and Accountability Act 
and was approved by the institutional 
review board at all participating insti-
tutions; informed consent was obtained 
from all patients. As an analysis of pre-
existing anonymized data, this retro-
spective study of prospectively collected 
data was exempt from additional insti-
tutional review board approval.
diffusing capacity for carbon monoxide 
(DLco), which are also the most com-
mon primary outcome variables used 
to assess progression in clinical trials. 
Known limitations of FVC and DLco in 
this context include lack of sensitivity 
to change and difficulty interpreting 
marginal changes of 5%–10% (2), em-
phasizing the need for more precise an-
atomically based measures of severity.
Extent of lung fibrosis on computed 
tomographic (CT) images is a recog-
nized marker of disease severity (3); 
correlates with prognosis, including 
mortality (4); and can replace DLco in 
a clinical model to determine risk of 
death (1). The ability to evaluate the 
extent of fibrosis noninvasively, cap-
turing the spatial and temporal het-
erogeneity typical of usual interstitial 
pneumonia (UIP), makes CT particu-
larly useful. However, visual identifi-
cation of a UIP pattern is impaired by 
interobserver variation, and results are 
generally communicated in nonspecific 
qualitative terms (5). Computer-based 
quantitative methods capitalize on de-
tailed information available on images 
and have the potential to increase pre-
cision and reproducibility in evaluation 
of IPF on CT images.
The relatively recent approval of 
drug therapies for IPF has generated 
excitement that better treatments are 
within reach (6). As new treatments 
are evaluated, there is a need for an ob-
jective anatomy-based measure of IPF 
that could be provided by quantitative 
CT. Such a technique would be valuable 
in clinical practice to assess prognosis, 
identify progression, and standardize 
assessment across a diverse group of 
radiologists. In clinical trials, quanti-
tative CT could be useful in the strat-
ification of baseline severity of disease 
and in the assessment of progression or 
improvement in response to treatment.
https://doi.org/10.1148/radiol.2017161177
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Advances in Knowledge
 n Extent of lung fibrosis deter-
mined with data-driven textural 
analysis (DTA) is associated with 
forced vital capacity (FVC) per-
centage predicted (r = 20.60, P 
, .001) and lung diffusing ca-
pacity for carbon monoxide 
(DLco) percentage predicted (r = 
20.68, P , .001) at baseline.
 n Change in DTA score is corre-
lated with change in FVC per-
centage predicted (r = 20.41, P 
, .001) and DLco percentage 
predicted (r = 20.40, P , .001) 
at 15-month follow-up.
 n Subjects with disease progression 
(n = 34) at visual assessment had 
greater mean DTA score at base-
line (32.93 vs 23.43, P = .003), 
poorer function (mean FVC per-
centage predicted: 69.82 vs 
78.34, P = .019; mean DLco per-
centage predicted: 41.91 vs 51.1, 
P , .001), and greater rates of 
change in these indexes over the 
follow-up period (change in DTA 
score: 6.6 vs 0.7, P , .001; 
change in FVC percentage pre-
dicted: 25.15 vs 21.27, P = 
.003; change in DLco percentage 
predicted: 25.59 vs 21.65, P = 
.004) when compared with 
patients who did not have 
disease progression.
Implication for Patient Care
 n Automatic quantification of lung 
fibrosis on CT images yields an 
index of severity that correlates 
with visual assessment and func-
tional change in subjects with 
idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF) is characterized by progressive scar-ring of the lungs and declining lung 
function, and it has a variable clinical 
course. Some patients experience pe-
riods of relative stability, while others 
have acute progression and rapid de-
cline. Accurate diagnosis and prediction 
of disease course are difficult, prompt-
ing interest in standardized quantitative 
measures of severity to assist in clin-
ical decision making and assessment 
of treatment efficacy in clinical trials 
(1,2). In clinical practice, disease se-
verity is assessed with physiology, most 
commonly by using pulmonary function 
tests (PFTs), including measurement 
of forced vital capacity (FVC) and lung 
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traction bronchiectasis) on CT images in 
55 subjects from the IPFnet ACE cohort 
that were used in dictionary construc-
tion. A senior thoracic radiologist (D.L., 
more than 20 years of experience) ver-
ified each ROI. Quantitative features 
were computed for 14 3 14 mm ROIs 
by using the previously constructed dic-
tionary. The features for a given 14 3 
14 mm ROI can be thought of as the 
frequency with which 3 3 3 mm sub-
regions matching learned dictionary ele-
ments occur in that ROI. These labeled 
exemplars were used to train a support 
vector machine (SVM) classifier. The 
SVM was trained in a binary fashion so 
that novel image regions described in 
terms of the established dictionary are 
classified as either a normal lung or a 
fibrotic lung (7). Hard negative mining, 
an iterative approach to training that 
emphasizes difficult-to-classify normal 
samples to reduce false-positive results, 
was used (14). Images of the 280 study 
subjects were not used to construct the 
dictionary or train the SVM classifier.
Analysis of study population CT 
studies began with semiautomatic lung 
segmentation with commercially avail-
able software (Apollo; Vida Diagnostics, 
Coralville, Iowa). Pixel histogram statis-
tics (mean, standard deviation, skew-
ness, and kurtosis) were computed over 
whole-lung volumes by using custom soft-
ware developed in-house. Square 14 3 14 
mm ROIs were sampled from within lung 
segmentation volumes and were classi-
fied with DTA as fibrotic or not fibrotic. 
DTA fibrosis score was computed as the 
number of ROIs classified as fibrotic di-
vided by the total number of ROIs sam-
pled from the lung segmentation volume.
Baseline CT Analysis
Volumetric CT of 280 subjects enrolled 
in ACE, PANTHER, and STEP IPFnet 
studies were used for testing (8–10). 
Two radiologists (J.H., K.Y.; 5 and 10 
years of experience, respectively) scored 
extent of fibrosis, expressing the visual 
extent of fibrotic abnormality to the 
nearest 10% on a scale from 0 (no fi-
brosis) to 10 (100% fibrosis) (15). Base-
line PFT data (FVC, FVC percentage 
predicted, DLco, and DLco percentage 
predicted) were available in all subjects.
equipment, and 52 were examined with 
Philips equipment.
Data in all subjects have been report-
ed previously (8–10); however, prior ar-
ticles dealt with experimental drug ther-
apies, whereas we report a new method 
to quantify lung fibrosis on CT images.
Quantitative CT Analysis
DTA is based on an unsupervised 
feature-learning paradigm. Briefly, 
this method uses an initial clustering 
analysis to “learn” feature representa-
tions directly from a large collection 
of unlabeled images (7). Unsupervised 
clustering produces a set of basis ele-
ments, called a dictionary, which can 
be used to encode other image regions. 
Dictionary elements tend to be simple 
features, like directed edges or blobs, 
and they can be considered a collection 
of the elemental low-level pixel patterns 
that occur at lung CT. Weighting coef-
ficients on dictionary elements needed 
to reconstruct novel image regions pro-
vide quantitative features useful for 
subsequent classification with machine 
learning. Unsupervised feature learning 
differs from feature engineering, which 
is a more traditional approach in which 
features are designed manually, often by 
using combinations of standard statisti-
cal or image processing calculations.
In our implementation, feature rep-
resentations were produced by clus-
tering thousands of small (3 3 3-mm) 
patches randomly sampled from lung 
regions on CT images in patients with 
IPF and in those without IPF. Images of 
the 55 subjects from the IPFnet ACE 
study, none of whom were included in 
this study cohort, served as examples 
of IPF. Images in nonsmoking control 
subjects from the Genetic Epidemi-
ology of COPD (COPDGene) cohort 
(n = 35) (12) were used as examples 
of non-IPF lungs. A modified k-means 
clustering process (13) on the pixel in-
tensities in these small patches yielded 
a 512-element dictionary of low-level 
CT patterns found in the lungs.
Separately, an experienced radiolo-
gist (K.Y., 10 years of experience) delin-
eated regions of interest (ROIs) showing 
the characteristic patterns of UIP (hon-
eycombing, reticular abnormality, and 
Subjects
For inclusion in the original studies, pa-
tients were required to have received 
a diagnosis of IPF according to stan-
dardized criteria similar to the subse-
quently published American Thoracic 
Society−European Respiratory Society 
criteria (11). Baseline CT examinations 
were performed within 3 months of en-
rollment. The minimal CT acquisition 
requirements for study entry were 0.5–
1.25-mm thick sections obtained at 1-cm 
intervals and at full inspiration. When 
feasible, subjects underwent multidetec-
tor thin-section CT according to a pre-
specified protocol, which was customized 
according to CT scanner manufacturer 
and model. PFTs to measure FVC and 
DLco were performed according to stan-
dardized protocols (8–10). Data were ac-
quired between 2007 and 2013.
CT studies that met minimal acqui-
sition requirements were available in 
539 subjects enrolled in the STEP, PAN-
THER, and ACE IPFnet trials (8–10). 
For this work, we selected subjects (n 
= 335) based on availability of thin-sec-
tion volumetric CT (image reconstruc-
tions  1.25 mm) and PFT data. From 
this group, we selected a subset from 
the ACE cohort for algorithm training 
data (n = 55; mean age, 65.8 years; age 
range, 50–78 years [38 men; mean age, 
65.3 years; age range, 50–78 years; 17 
women; mean age, 67.1 years; age 
range, 54–75 years]). These subjects 
were selected for training because they 
had been examined with equipment 
from the most commonly used manu-
facturers (GE Healthcare, Waukesha, 
Wis; Siemens Healthineers, Erlangen, 
Germany) and because they had appro-
priate examples of the fibrotic UIP pat-
tern. Twenty-two of these studies were 
acquired with Siemens equipment, and 
33 were obtained with GE units. The 
remaining subjects with thin-section 
volumetric CT studies comprise the 
study subjects for this project (n = 280; 
mean age, 67.5 years; age range, 43–86 
years [216 men; mean age, 67.9 years; 
age range, 48–86 years; 64 women; 
mean age, 66.3 years; age range, 43–
84 years]). A total of 139 study sub-
jects were examined with GE equip-
ment, 89 were examined with Siemens 
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whether DTA fibrosis score significantly 
improved prediction of clinical outcomes 
(17). Base models used visual score, CT 
histogram-based measures (mean, stan-
dard deviation, skewness, and kurtosis 
of lung voxel values), or both. Models 
for baseline data included one term per 
predictor (1 for visual score, 4 for CT 
histogram-based measures, 1 for DTA fi-
brosis score), while longitudinal models 
included two terms for each predictor 
(variable itself plus time-by-variable in-
teraction). Thus, asymptotic tests for 
added benefit of DTA score used one 
degree of freedom in models for base-
line data and two degrees of freedom 
in longitudinal models. Linear mixed 
models included a random intercept 
term for CT reconstruction kernel plus 
random terms for subject (in longitudi-
nal models) and reader (in models for 
visual extent).
Results
Table 1 summarizes subject demo-
graphics. A subset of 72 subjects from 
weighted k scores. The k agreement 
scores were interpreted by using the 
following criteria: k of 0.0–0.2 indi-
cated slight agreement; k of 0.21–0.40, 
fair agreement; k of 0.41–0.60, moder-
ate agreement; k of 0.61–0.80, substan-
tial agreement; and k of 0.81–1.0, al-
most perfect agreement (16). Subjects 
whose follow-up CT images were scored 
as slightly worse or much worse by at 
least two reviewers were considered to 
have progressed. Welch two-sample t 
tests were performed to compare base-
line scores and rates of change between 
subjects whose disease had progressed 
and those whose disease had not.
Linear mixed models were used to 
evaluate multiple CT-derived approaches 
in predicting FVC or DLco for both base-
line and longitudinal data. In particular, 
histogram, DTA, and visual-based vari-
ables were included as predictors in FVC 
or DLco models separately or together to 
determine their predictive utility or add-
ed benefit. Asymptotic x2 tests using the 
difference in two log likelihoods between 
nested models were used to determine 
Serial CT Evaluation
A subset of 72 subjects (51 men; mean 
age, 66.9 years; age range, 49–82 years; 
21 women; mean age, 65.8 years; age 
range, 43–84 years) enrolled in the 
PANTHER study underwent both base-
line and follow-up volumetric CT. The 
resultant images were evaluated inde-
pendently by three senior thoracic ra-
diologists (D.L., E.K., E.v.B.; all with 
more than 15 years of experience). 
Semiquantitative scores (scale, 0–10) 
for extent of fibrosis were assigned for 
each study. Visual assessment of change 
in fibrosis at follow-up was performed by 
comparing both studies and was scored 
on a five-point ordinal scale (0, much 
better; 1, slightly better; 2, same; 3, 
slightly worse; 4, much worse). Baseline 
and follow-up PFT results were avail-
able for all 72 subjects. FVC and FVC 
percentage predicted were measured at 
baseline and at 15, 30, 45, and 60 weeks 
thereafter. DLco and DLco percentage 
predicted were measured at baseline 
and at 30 and 60 weeks thereafter.
Statistical Analyses
Statistical analyses were performed 
by using two software packages (R, 
version 3.0.0, R Foundation for Sta-
tistical Computing, Vienna, Austria; 
SAS, version 9.4, SAS Institute, Cary, 
NC). Level of significance was set to P 
, .05 for all experiments, and correc-
tion for multiple comparisons was not 
applied. Spearman correlation coeffi-
cients were used to quantify univariate 
relationships between DTA scores, CT 
histogram-based measures (mean lung 
attenuation, standard deviation of lung 
pixel intensities, skewness, and kur-
tosis), semiquantitative visual scores, 
and physiologic measures (FVC, FVC 
percentage predicted, DLco, and DLco 
percentage predicted). Follow-up data 
were analyzed descriptively with Spear-
man correlation coefficients by con-
sidering change scores (last follow-up 
measurement minus baseline mea-
surement) and rate of change (slope 
determined by linear regression of all 
follow-up measurements). For visual 
assessments, the mean of reviewers’ 
scores was used in all analyses. Inter-
rater agreement was evaluated with 
Table 1
Study Subject Characteristics
Characteristic
Baseline IPFNet (ACE,  
PANTHER, and STEP)  
(n = 280)
PANTHER (n = 72)
Baseline
Change at  
Follow-up P Value*
Age (y) 67.5 6 8.6 66.6 6 9.2 … ,.001
Visual extent of fibrosis score† 4.24 6 1.5 1.7 6 0.7 0.3 6 0.5 ,.001
Visual assessment of change score‡ … … 2.5 6 0.6 ,.001
DTA fibrosis score 36.6 6 16.1 27.9 6 13.4 4.0 6 6.7 ,.001
Mean lung attenuation (HU) 2714.0 6 65.5 2728.9 6 53.7 9.5 6 32.6 .020
Standard deviation of lung attenuation 
(HU)
223.1 6 34.2 208.8 6 27.2 1.2 6 15.8 .520
Skewness 1.7 6 0.5 1.9 6 0.5 20.1 6 0.2 ,.001
Kurtosis 3.1 6 2.6 3.9 6 2.3 20.4 6 1.1 .002
CT total lung capacity (L) 3.7 6 1.1 3.9 6 1.0 20.1 6 0.4 .230
FVC (L) 2.7 6 0.9 2.9 6 0.7 20.1 6 0.3 ,.001
FVC percentage predicted 66.2 6 17.5 74.3 6 15.4 23.4 6 6.5 ,.001
DLco (mL of CO/min/mm Hg) 11.3 6 4.4 13.8 6 4.2 21.2 6 2.2 ,.001
DLco percentage predicted 38.0 6 13.4 46.8 6 132.1 24.3 6 7.1 ,.001
* P values were calculated with the one-sample t test.
† Semiquantitative extent of fibrosis was scored on a scale from 0 to 10. For subjects in the IPFnet study, scores at baseline were 
assigned by two reviewers (K.Y., J.H.). For patients in the PANTHER study, scores at baseline and follow-up were assigned by 
three reviewers (D.A.L., E.J.R.v.B., E.A.K.), and change at follow-up was calculated as follow-up score minus baseline score.
‡ Average of three readers (D.A.L., E.J.R.v.B., E.A.K.); a follow-up score of 0 indicated fibrosis was much better; a score of 1, 
fibrosis was slightly better; a score of 2, fibrosis was the same; a score of 3, fibrosis was worse; and a score of 4, fibrosis was 
much worse.
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agreement (mean of pairwise weighted 
k = 0.3, P , .05, n = 72). Agreement 
for extent of fibrosis scores at baseline 
and at follow-up (assigned by the same 
three readers) was moderate (mean 
pairwise k = 0.53, P , .001). Subjects 
identified at visual assessment as hav-
ing disease progression had higher DTA 
score and poorer PFT at baseline and 
had greater rates of change in these 
measurements over the follow-up pe-
riod (Table 3).
assessment, and PFTs. Radiologist 
agreement for semiquantitative fibrosis 
scores at baseline (assigned by two ra-
diologists) was poor by weighted k (k = 
0.3, P , .001, n = 280). However, DTA 
score showed moderate correlation 
with average visual score (Spearman r 
= 0.50, P , .001).
In the 72 subjects who under-
went follow-up CT, the evaluation of 
agreement between three reviewers’ vi-
sual assessment of change showed poor 
the PANTHER study underwent vol-
umetric CT and PFT both at baseline 
and at follow-up. The follow-up inter-
val ranged from 13.1 to 18.2 months 
(mean, 14.9 months 6 0.93 [standard 
deviation]; median, 14.7 months). 
The Figure shows visualization of DTA 
analysis results for baseline and fol-
low-up images.
Table 2 shows associations be-
tween baseline values and rates of 
change of CT-derived measures, visual 
A, Axial baseline unenhanced CT image in a 60-year-old man. B, Areas of fibrosis identified with DTA are indicated (red ). Baseline DTA 
fibrosis score was 22.3%, average visual extent of fibrosis as assessed by three readers (D.L., E.v.B., E.K.) was 1.67, baseline FVC percentage 
predicted was 53.15, and DLco percentage predicted was 36.1. C, Similar axial unenhanced CT image in the same subject at 18.2-month 
follow-up. D, DTA fibrosis score was 40.6% at follow-up, average visual extent of fibrosis (D.L., E.v.B., and E.K.) was 3.67, with all three readers 
scoring the follow-up image as slightly worse. Follow-up FVC percentage predicted was 44.4 and DLco percentage predicted was 30.5.
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CT-derived measurements were 
predictive of PFT outcomes for both 
baseline and longitudinal data based 
on linear mixed models. The main out-
come variables analyzed (FVC, DLco) 
are approximately normally distributed 
based on examination of histograms. 
Table 4 shows the added benefit, based 
on asymptotic x2 tests, of including 
DTA score in models predicting FVC 
or DLco by using visual score, histo-
gram measurement metrics, or both. 
The most significant improvements oc-
curred when we included DTA score 
in models with visual score only (P , 
.001) and for all longitudinal models of 
DLco, including those with visual score, 
histogram measurements, or both (P , 
.001).
Discussion
We have developed a computer algo-
rithm capable of quantifying extent 
of lung fibrosis on CT images. In 280 
subjects with IPF, DTA fibrosis score 
showed correlation with semiquanti-
tative visual scores and PFTs at base-
line. In a subset of 72 subjects with 
baseline and follow-up CT images, DTA 
score showed moderate significant cor-
relation with the degree of change in 
PFTs. This indicates that extent of lung 
fibrosis captured on CT images and 
quantified with DTA is associated with 
change in lung function. The purpose 
of comparing quantitative CT images 
with lung function is not to suggest 
that CT can or should replace PFTs. 
Our intent is to perform a clinical vali-
dation of CT analysis methods to show 
that measurement of morphology is as-
sociated with measures of disease se-
verity; however, textural analysis may 
yield a more sensitive index of longi-
tudinal change that may be in part in-
dependent of physiologic change. We 
focused on FVC and DLco because 
these measures are recommended for 
evaluation of disease course by the 
American Thoracic Society, European 
Respiratory Society, Japanese Resip-
ratory Society, and Latin American 
Thoracic Association official guidelines 
on IPF (11). Multivariate analysis for 
prediction of lung function showed T
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to identify regions of interstitial lung 
abnormality. Local pixel histograms 
can yield more information. Iwasawa 
et al (20) described a method in which 
histograms of pixel intensities and 
gradients within ROIs were compared 
by using normalized correlation. They 
determined that the extent of a his-
togram pattern associated with hon-
eycombing based on comparison with 
radiologist-identified exemplars was 
associated with mortality in a group 
of 40 patients with IPF. Bartholmai et 
al (21) and Maldonado et al (22) also 
used local histograms but classified 
small volumes of interest on thin-sec-
tion CT images by using an approach 
based on clustering of expert-labeled 
volumes of interest by affinity propa-
gation. By using this method to deter-
mine extents of UIP patterns on CT 
images, they reported correlations 
between automatic scores and other 
clinical measures in 119 subjects with 
interstitial lung disease.
Histograms count frequency of in-
dividual pixel intensities but do not 
explicitly capture local visually dis-
tinct patterns like edges or curves. 
The characteristic appearance of UIP 
on CT images is formed by patterns 
in both pixel intensity and spatial ar-
rangement, a quality called image tex-
ture. Researchers have applied image 
texture methods to the problem of 
automatic analysis of interstitial lung 
disease on CT images and have shown 
impressive results (18,23,24). Kim et 
al (25) developed a method in which 
texture features computed by using 
local first- and second-order pixel 
statistics are classified with an SVM 
Table 3
Comparison of Baseline Values and Change in Subjects Who Had Progressed and 
Those Who Had Not Based on 5% Decline in FVC Percentage Predicted and Visual 
Assessment
A: 5% Decline in FVC Percentage Predicted
Characteristic Nonprogressors (n = 42) Progressors (n = 30) P Value*
Baseline
 DTA score 25.38 6 11.21 28.41 6 11.42 .273
 DLco percentage predicted 47.72 6 11.46 45.42 6 12.97 .439
 Visual extent† 1.70 6 0.63 1.80 6 0.74 .561
Rate of change (per year)
 DTA score 1.71 6 5.0 6.92 6 7.63 .002
 DLco percentage predicted 22.67 6 6.96 26.52 6 6.84 .023
 Visual assessment of change† 0.33 6 0.61 0.822 6 0.58 ,.001
B: Visual Assessment
Characteristic Nonprogressors (n = 38) Progressors (n = 34) P Value*
Baseline
 DTA score 23.43 6 11.02 32.93 6 14.16 .003
 FVC percentage predicted 78.34 6 13.53 69.82 6 16.23 .020
 DLco percentage predicted 51.10 6 12.60 41.91 6 9.49 ,.001
Rate of change (per year)
 DTA score 0.70 6 3.61 6.6 6 5.68 ,.001
 FVC percentage predicted 21.27 6 4.94 25.15 6 5.56 .003
 DLco percentage predicted 21.65 6 5.67 25.59 6 5.58 .004
Note.—Unless otherwise indicated, data are mean 6 standard deviation.
* Welch two-sample t test.
† Average of three readers.
Table 4
P Values for Improvement in Goodness of Fit after Adding Algorithm Score as a Predictor in Clinical Outcome Models
Adding DTA score to Model with the Following Base Predictors
Baseline Data Longitudinal Data
FVC Percentage Predicted DLco Percentage Predicted FVC Percentage Predicted DLco Percentage Predicted
Visual score ,.001 (81.8) [1] ,.001 (93.9) [1] ,.001 (17.2) [2] ,.001 (53.5) [2]
Histogram measures .007 (7.2) [1] .005 (7.9) [1] .061 (5.6) [2] ,.001 (29.2) [2]
Histogram measures and visual score .008 (7) [1] .032 (4.6) [1] .301 (2.4) [2] ,.001 (24.8) [2]
Note.—Data are P values. Data in parentheses are the x2 statistic, and data in brackets are degrees of freedom. Asymptotic x2 tests for differences in 22 log likelihood values were used to determine 
significance of improvement when adding algorithm score as a predictor in linear mixed models; see text for more detail. 
DTA score adds information beyond 
histogram-based measurements and 
semiquantitative visual scores.
It is known that lung pixel histo-
gram statistics, including skewness and 
kurtosis, correlate with baseline phys-
iologic parameters, including FVC and 
DLco (4,17). Although these measures 
are attractive in that they are easy to 
calculate and are fairly intuitive, they 
are coarse global metrics that are not 
sufficiently precise for longitudinal 
analysis (4,18).
Automatic localization of inter-
stitial lung disease on CT images is 
a challenging task. Fibrotic patterns 
are complex and are not defined ad-
equately by using simple quantitative 
descriptors. Kliment et al (19) studied 
a large population and showed that 
attenuation value alone, separated by 
applying a threshold, is not sufficient 
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trained in a supervised fashion using 
radiologist-delineated regions of lung 
fibrosis. In a study of 57 subjects with 
IPF and sequential CT examinations 
selected from a database of standard-
ized scans, fibrosis scores computed 
with their method were associated 
with baseline FVC and DLco and 
change in these measurements after 
7 months (18). Yoon et al (26) used a 
similar texture-based system to quan-
tify disease patterns of fibrotic inter-
stitial pneumonia at sequential CT in 
89 subjects with clinically proven and/
or biopsy proven UIP or nonspecific 
interstitial pneumonia. They showed 
there was an association between 
quantitative and visual scores, FVC 
and DLco at baseline, and change in 
FVC and DLco at 1 year follow-up. 
Correlations between DTA score and 
PFTs in the present study were simi-
lar to those reported by these inves-
tigators. Several recently developed 
classification systems have sought to 
subcategorize disease patterns into 
specific categories, including ground-
glass abnormality, reticulation, and 
honeycombing (15,27). However, we 
chose to focus this analysis on the 
extent of fibrosis because in patients 
with IPF, the extent of fibrosis or re-
ticular abnormality is invariably the 
most important in correlating with 
pulmonary function and outcome 
(28,29).
Most established image texture 
methods are based on engineered fea-
tures, meaning calculation strategies 
designed to capture particular char-
acteristics anticipated to be useful 
in distinguishing patterns of interest. 
These approaches can be limited in 
that they are based on assumptions 
regarding which characteristics are 
important, and they generally rely 
on multiple parameters that must be 
tuned, often by trial and error. The 
typical approach computes a battery 
of features then applies feature selec-
tion to identify those that are useful in 
the classification task. Unsupervised 
feature learning distills descriptive 
feature representations directly from 
a large collection of relevant data. 
Mounting evidence suggests this type 
of approach yields image features that 
are more powerful than engineered 
features (30), thereby providing more 
discriminative information for classi-
fier training. This is the strategy used 
in DTA. A supervised classifier was 
trained by using radiologist-labeled 
regions, from which features were 
extracted by using a framework de-
veloped in an unsupervised process 
rather than by using designed fea-
tures. There was no overlap in images 
used to develop the DTA algorithm, 
including construction of the feature 
dictionary and training the classi-
fier, and the images analyzed in this 
study. Classification systems based 
on learned features are thought to be 
more flexible and easier to generalize 
to similar tasks (eg, classification of 
other CT patterns) than those based 
on engineered features (31).
Limitations of this study include 
variation in CT technical parame-
ters, the relatively small number of 
subjects who underwent a follow-up 
examination, and the absence of mor-
tality data. CT technical parameters, 
such as reconstruction kernel, affect 
image sharpness and noise level, 
which likely affect quantitative CT 
measures. The use of a random inter-
cept term for reconstruction kernel in 
the linear mixed model accounts for 
this at multivariate analysis, but vari-
ation in CT technical parameters may 
contribute to the relatively low cor-
relations at univariate analysis. The 
use of FVC and DLco as the reference 
standard for disease severity is inher-
ently flawed because of known varia-
tion in these measures and because 
of the inevitable incongruity of phys-
iologic and anatomic measurements. 
This may explain the relatively mod-
est correlations between the CT-based 
and physiologic measurements. The 
lack of correction for multiple com-
parisons can also be considered a lim-
itation; however, we chose to present 
individual P values for the planned 
comparisons. The observer variation 
for visual assessment is a known lim-
itation that has been demonstrated 
in this study and in prior studies, but 
it emphasizes the difficulty of visual 
quantification and the need for an 
automated method. We also did not 
perform a direct comparison of DTA 
with other published fibrosis quanti-
fication methods. Nevertheless, a key 
conclusion from this and related work 
is that CT captures useful prognostic 
information that can be quantified by 
using computational techniques.
We conclude that DTA fibrosis score 
applied to CT from a multicenter study 
of IPF correlates with visual assess-
ment and PFTs at baseline and when 
assessing change. Multivariate analysis 
indicates that DTA score improves the 
ability to predict change in function 
over time. Our findings that DTA fibro-
sis score is associated with baseline 
measurements of disease severity and 
with change over time suggest that CT 
captures anatomic information that can 
be quantified by using automatic com-
putational methods to provide useful 
indexes of disease severity and progres-
sion in patients with IPF.
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